Skip to main content

Table 1 Demographic data, original renal disease, laboratory and dialysis related data of the study group (n = 187)

From: Vascular access challenges in hemodialysis children

Variable

Sex:

 Male

N (%)

104 (55.6%)

 Female

N (%)

83 (44.4%)

 Age (years)

mean ± SD

8.3 ± 3.675

 Dry weight (Kg)

mean ± SD

16.6 ± 7.6

Original kidney disease:

 FSGS

N (%)

53 (28.5%)

 NPHP

N (%)

42 (22.4%)

 Obstructive Uropathy

N (%)

41 (21.9%)

 PH1

N (%)

16 (8.5%)

 Cystinosis

N (%)

9 (4.8%)

 aHUS

N (%)

8 (4.27%)

 Joubert Syndrome

N (%)

6 (3.2%)

aOthers

N (%)

12 (6.4%)

Dialysis duration (months)

mean ± SD

17.73 ± 10.607

Laboratory data:

 Hemoglobin (g/dl)

mean ± SD

10.09 ± 2.789

 Serum calcium

mean ± SD

9.78 ± 2.012

 Serum Phosphorus

mean ± SD

8.14 ± 3.941

Comorbidities:

 Anemia

N (%)

56 (29.9%)

 Hypertension

N (%)

63(33.6%)

 Cardiomyopathy

N (%)

47 (25.1%)

HCV status:

 HCV PCR + ve

N (%)

32 (17.1%)

 HCV PCR –ve

N (%)

155 (82.9%)

  1. aHUS atypical hemolytic uremic syndrome, HCV Hepatitis c virus, FSGS Focal segmental glomerulosclerosis, NPHP Nephronophthisis, PCR Polymerase chain reaction, PH1 Primary hyperoxaluria type1
  2. aOthers include: autosomal recessive polycystic kidney disease, Membranoproliferative glomerulonephritis, lupus nephritis and bilateral atrophic kidney